Theralase Technologies Inc. V.TLT

ALL IN ALL looks like a decent REPORT!

[skyhawk1]

However I do agree that the 'PENDING' serves NO positive purpose?! Y not wait until 'pending' becomes FACT!! Who wrote this CHRISTINA?! LoL
 

ACCUMULATION continues!  G'day SUPER LONGS!!

[enriquesuave]

Yes results look good for patients treated with optimized procedure.  We just need more data to confirm and get a better idea of exact efficacy numbers.  

[jicoop]

decent report, not to be lost in all this : Study II utilizes the Therapeutic Dose (0.70 mg/cm2) of TLD-1433, activated by the TLC-3200, and is focused on the enrollment and treatment of approximately 100 BCG-Unresponsive NMIBC CIS patients in up to 20 clinical study sites located in Canada and the US. Must remember these patients have failed the first line treatment, so are already presenting

[Eoganacht]

If you just look at the 6 patients who recieved the optimized procedure in phase 2 it is still possible to hit 83% CR at 180 days for that population. If you include the 7 patients still to come before we reach 25 (13 patients with optimized treatment), it is still possible to achieve 92% CR at 180 days. Not likely - but not impossible. For that you would need all of the last 10 patients of